Growth inhibition of A549 human lung adenocarcinoma cells by L-canavanine is associated with p21/WAF1 induction

被引:9
|
作者
Ding, Y
Matsukawa, Y
Ohtani-Fujita, N
Kato, D
Dao, S
Fujii, T
Naito, Y
Yoshikawa, T
Sakai, T [1 ]
Rosenthal, GA
机构
[1] Kyoto Prefectural Univ Med, Dept Prevent Med, Kamigyo Ku, Kyoto 6028566, Japan
[2] Kyoto Prefectural Univ Med, Dept Surg 2, Kamigyo Ku, Kyoto 6028566, Japan
[3] Kyoto Prefectural Univ Med, Dept Med 1, Kamigyo Ku, Kyoto 6028566, Japan
[4] Univ Kentucky, Lab Biochem Ecol, Lexington, KY 40506 USA
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1999年 / 90卷 / 01期
关键词
L-canavanine; p21/WAF1; p53; RB; cell cycle;
D O I
10.1111/j.1349-7006.1999.tb00667.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
L-Canavanine (CAV) is a higher plant nonprotein amino acid and a potent L-arginine antimetabolite, CAV can inhibit the proliferation of tumor cells in vitro and in vivo, but little is known regarding the molecular mechanisms mediating these effects, We demonstrated that the treatment of human lung adenocarcinoma A549 cells with CAV caused growth inhibition; G1 phase arrest is accompanied by accumulation of an incompletely phosphorylated form of the retinoblastoma protein, whose phosphorylation is necessary for cell cycle progression from G1 to S phase. Zn addition, CAV induces the expression of p53 and subsequent expression of a cyclin-dependent kinase inhibitor, p21/WAF1. The p53-dependent induction of p21/WAF1 and the following dephosphorylation of the retinoblastoma protein by CAV could account for the observed CAV-mediated G1 phase arrest.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 50 条
  • [1] Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells
    Bai, FL
    Matsui, T
    Ohtani-Fujita, N
    Matsukawa, Y
    Ding, Y
    Sakai, T
    FEBS LETTERS, 1998, 437 (1-2) : 61 - 64
  • [2] P21(WAF1) mutations and human malignancies
    Shiohara, M
    Koike, K
    Komiyama, A
    Koeffler, HP
    LEUKEMIA & LYMPHOMA, 1997, 26 (1-2) : 35 - 41
  • [3] Induction of p21(waf1) expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells
    Grau, AM
    Zhang, L
    Wang, WX
    Ruan, SB
    Evans, DB
    Abbruzzese, JL
    Zhang, W
    Chiao, PJ
    CANCER RESEARCH, 1997, 57 (18) : 3929 - 3934
  • [4] MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21(WAF1)
    Xie, W
    Su, KH
    Wang, DY
    Paterson, AJ
    Kudlow, JE
    ANTICANCER RESEARCH, 1997, 17 (4A) : 2627 - 2633
  • [5] Absence of a mutation of the p21/WAF1 gene in human lung and pancreatic cancers
    Shimizu, T
    Miwa, W
    Nakamori, S
    Ishikawa, O
    Konishi, Y
    Sekiya, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (03): : 275 - 278
  • [6] Analysis of p21(Waf1/Cip1) expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma
    Hayashi, H
    Miyamoto, H
    Ito, T
    Kameda, Y
    Nakamura, N
    Kubota, Y
    Kitamura, H
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (02): : 461 - 470
  • [7] Repair defect in p21(WAF1/CIP1) -/- human cancer cells
    McDonald, E
    Wu, GS
    Waldman, T
    ElDeiry, WS
    CANCER RESEARCH, 1996, 56 (10) : 2250 - 2255
  • [8] p53/p21((waf1/cip1)) expression in human lung cancer
    Bennett, WP
    ElDeiry, WS
    Guinee, DG
    Caporaso, NE
    Welsh, JA
    Jones, RT
    Borkowski, A
    Travis, WD
    Colby, TV
    Trastek, V
    Pairolero, PC
    Tazelaar, HF
    Midthun, D
    Jett, JR
    Liotta, LA
    Vogelstein, B
    Harris, CC
    LABORATORY INVESTIGATION, 1996, 74 (01) : 895 - 895
  • [9] Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor
    Shima, N
    Stolz, DB
    Miyazaki, M
    Gohda, E
    Higashio, K
    Michalopoulos, GK
    JOURNAL OF CELLULAR PHYSIOLOGY, 1998, 177 (01) : 130 - 136
  • [10] p21/WAF1 mRNA and protein expression in human hepatocellular carcinoma
    Ng, IOL
    Qin, LF
    Fan, ST
    Lee, JMF
    Ng, M
    GASTROENTEROLOGY, 1999, 116 (04) : A1254 - A1254